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Life After Menopause: Quality of Life in Women Diagnosed with PolyCystic Ovarian Syndrome 
after the Childbearing Years 
Review of Literature 
Polycystic Ovarian Syndrome (PCOS) is a complex, multi-symptom endocrine chronic 
illness that affects 1 out of every 15 women (Trivax & Azziz, 2007). According to an official 
website for PCOS, pcosaa.org (2017), symptoms of PCOS include irregular or missed periods, 
cysts on the ovaries, weight gain, fatigue, unwanted hair growth (hirsutism), thinning hair on the 
head, infertility, acne, mood changes, pelvic pain, headaches, sleep problems, insulin resistance, 
slow metabolism, and hypoandrogenism. Women diagnosed with PCOS have a higher risk for 
obesity, diabetes, eating disorders, and cardiovascular disease (Ferrell-Turner, 2015). It is 
important to note that PCOS looks different in every woman. Some women may have all of these 
symptoms while some may only have a few.  
In addition to the multitude of the physical symptoms that accompany PCOS, there are 
also many mental health problems. However, the psychological effects of the disease often go 
undiscussed; “[O]f more than 2100 PubMed citations on PCOS appearing since 2000, only 3% 
addressed psychological concerns” (Himelein & Thatcher, 2006, p. 723). PCOS can also be 
associated with depression, anxiety, body dissatisfaction, difficulties with sexual and relational 
functioning, lower quality of life, eating disorders, anger, and aggression (Himelein & Thatchar, 
2006).  
PCOS is normally only recognized and diagnosed in women who are in their childbearing 
years (Trivax & Azziz, 2007). While there has been a multitude of research conducted around 
the area of perceived quality of life in pre-menopausal women that have been diagnosed with 
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PCOS, there is very little that has been conducted about the perceived quality of life in post-
menopausal women diagnosed with PCOS. This lack of research may be due to a scientific and 
societal disinterest in women with PCOS once they are no longer able to bear children. However, 
while the perceived quality of life in pre-menopausal women diagnosed with PCOS may be 
interesting and important, women eventually age and experience menopause. Knowing what life 
post-menopause might look like for women diagnosed with PCOS is an area of research that 
needs to be explored.  
To understand what PCOS looks like from a post-menopausal mental health perspective, 
it is first important to comprehend what PCOS is from a pre-menopausal mental health 
perspective. Per Ferrell-Turner (2015), “PCOS is the most common cause of female infertility, 
which in and of itself is associated with adverse psychosocial functioning” (p. 49). A study 
conducted in 2009 analyzed 60 women with a confirmed diagnosis of PCOS using The Primary 
Care Evaluation of Mental Disorders Patient Health Questionnaire. Among the women who 
participated in the study, the prevalence of depression was 40% and the prevalence of mood 
disorders was 56.6% (Kerchner, Lester, Stuart, & Dokras, 2009).  
In addition to depression and mood disorders, anxiety is also 
higher among women with a PCOS diagnosis. It was discovered that 
anxiety is higher than depression in women with PCOS (although 
underdiagnosed) and that higher levels of depression were found in 
women who were deemed infertile (Deeks, Gibson-Helm, & Teede, 2010). 
Also, Jedel, Waern, Gustafson, Landen, Eriksson, Holm, Nilsson, Lind, 
Janson, and Stener-Victorin (2009), conducted a study that consisted 
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of 52 women (25 with PCOS, 27 in the control group without PCOS). 
Participants were given the Brief Scale for Anxiety (BSA-S) with 
controls matched for Body Mass Index (BMI). This study found was that 
63% of women with PCOS received elevated scores on the BSA-S (≥11) 
while only 13% of the control group indicated elevated scores (≥11). 
The study concluded that half of the women with PCOS reported worry 
which is more than double compared to the control group (Jedel et 
al., 2009).  
A study conducted in 2008 further supports the claim that PCOS negatively affects 
mental health, and more specifically, anxiety. The study was comprised of 49 women with PCOS 
and 49 women without (control group). They discovered a lifetime diagnosis of Generalized 
Anxiety Disorder in 17% of the women (Jedel et al., 2009 per Mansson, Holte, Landin-
Wilhelmsen, Dahlgren, Johansson, & Landen, 2008). In addition, this study also concluded that 
women with PCOS had higher correlations with depressive episodes, social phobia, and eating 
disorders when compared to the controls. Also, they discovered that suicide attempts were seven 
times more common in the PCOS group than in the controls as well as a higher lifetime use of 
antidepressants and anxiolytic drugs (Mansson et al., 2008). 
Mental health is often correlated to overall quality of life (QOL). Women diagnosed with 
PCOS often have a lower QOL compared to women without PCOS (Barnard, Ferriday, 
Guenther, Strauss, Balen, & Dye, 2007). A study was conducted by Barnard et al. to examine the 
QOL in women with PCOS by using the PCOSQ, a QOL measure directed solely at measuring 
the QOL of women with PCOS. This measure consists of 26 items on a 7-point scale. Five 
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factors within the assessment include emotional disturbances, hirsutism, weight difficulties, 
infertility, and menstrual difficulties. The authors of the study created an additional factor, acne, 
in an attempt to increase the validity due to shortcomings of the assessment in previous research 
(Barnard et al., 2007). The total number of participants for the study was 409 women. They were 
placed into 4 randomized groups: women with PCOS not taking anti-androgen (AA) medication, 
women with PCOS taking AA medication, healthy women not taking AA medication, and 
healthy women taking AA medication. “Women were excluded if they were pregnant, peri- or 
post-menopausal, had no ovaries, were unsure whether they had ovaries, or were taking hormone 
replacement therapy” (Bernard et al., 2007, p. 2280). The study concluded that “The two PCOS 
groups had significantly worse QOL than control groups on all seven factors of the modified 
PCOSQ” (Barnard et al., 2007, p. 2283).  
So, what happens when women with PCOS are no longer able to bear children? Since the 
focal point of the disease is infertility, what happens when a woman reaches menopause or 
undergoes a hysterectomy? Per Welt and Carmina (2013) there is very little research available in 
reference to what PCOS looks like post-menopause. What they did discover, however, is that 
many of the physical symptoms stay the same or even worsen; typically, the onset of menopause 
is later in women with PCOS than in women without, there is a greater risk of hypertension, a 
greater risk for developing Type II Diabetes, higher insulin levels, cardiovascular issues, higher 
BMI’s, higher cholesterol, higher triglyceride levels, and worsened metabolic properties (Welt 
and Carmina, 2013, Felton & Panay, 2008). Also, ovarian cysts are common in 37% of post-
menopausal women according to a study conducted by Birdsall and Farquhar (1996). A 
longitudinal study that was published in 1992 by Dahlgren, Johansson, Lindstedt, Knuttson, 
Oden, Janson, and Lundberg had similar findings to the 2013 study conducted by Welt and 
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Carmina (2013). They discovered that women with PCOS undergo more hysterectomies 
compared to women without PCOS and there is also a higher prevalence of obesity, basal serum 
insulin concentration, diabeted millitus, hypertension, anovulation, hirsutism, and infertility. The 
older date and the number of years between the studies helps to further support the idea that 
PCOS in post-menopausal women is grossly understudied.  
As stated above, infertility is one of the major reasons that women with PCOS develop 
mental health issues (Ferrell-Turner, 2015). Once a woman goes through menopause or has a 
hysterectomy, child-bearing is no longer an option. Post-menopause mental health can be 
affected by this in one of two ways: women with PCOS may no longer feel an intense pressure to 
try to conceive and their mental health may improve, or, women with PCOS may experience 
worsened mental health due to the hopelessness of never being able to conceive a child. A study 
was conducted that evaluated women 11-17 years after they received fertilization treatment 
(Gameiro, van den Belt-Dusebout, Bleiker, Braat, Leeuwen, & Verhaak, 2014). What the study 
found is that women who still had a child-wish were “1.5 to 2.8 times more likely to develop 
clinically significant mental health problems than women without a child-wish” regardless of 
infertility diagnosis, treatment history, and outcome (Gameiro et al., 2014, p. 2243). However, 
the study also concluded that the majority of women are able to come to terms with their 
infertility and only a few develop mental health problems due to their child-wish (Gameiro et al., 
2014). This would suggest that women with PCOS who are post-menopause are able to adapt to 
their childlessness status and are therefore more likely to have a greater quality of life. 
Summary, Specific Aims, and Hypotheses 
 The current literature appears to clearly indicate that PCOS negatively affects the Quality 
of Life in those diagnosed with the disease. However, the exclusion criteria of these studies 
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include peri-menopausal, post-menopausal, and women without ovaries or those who have 
received hysterectomy’s. Welt and Carmina (2013) describe the medical aspect of what happens 
to women who have been diagnosed with PCOS after they are no longer considered “fertile.” 
Unfortunately, there is little to no research conducted on the QOL in women with PCOS past the 
age of 35.  
 This study aims to examine the quality of life in pre-menopausal women compared to 
post-menopausal women that have been diagnosed with PCOS. It is hypothesized that post-
menopausal women diagnosed with PCOS will have a higher perceived quality of life than pre-
menopausal women diagnosed with PCOS. The independent variable of this study is pre-versus- 
post-menopause and the dependent variable is the self-reported QOL. 
Methods 
Study Design 
A Cross-Sectional Design was utilized in this study. The rationale for using this study 
design is that it helped to examine variables (pre-and-post menopause in women diagnosed with 
PCOS) that are associated with the factor of interest (quality of life). This type of study design is 
best suited for this study and helped to provide the most concise results possible.  
Measures 
 The Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ-50) was the 
assessment tool utilized in this study. The PCOSQ-50 consists of 26 items related to 5 domains, 
each one related to a symptom of PCOS: body hair, emotions, infertility, weight difficulties, and 
menstrual difficulties. The measure is based on a 5-point scale with 1 being optimal functioning 
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and 5 being poorest functioning (Cronin, Goyatt, Griffith, Wang, Azziz, Futterweit, Cook, & 
Dunaif, 1998).  
 This questionnaire demonstrates high construct validity, internal reliability (.73-.97), and 
high face validity. Intra-class correlation coefficients to evaluate the test-retest reliability were 
high for all domains (range .89 - .95, P < 0.001). However, validity could be increased with the 
addition of an “acne” domain. Overall, this was the most appropriate assessment tool to utilize in 
this study because it is the only QOL measurement tool normed for women diagnosed with 
PCOS and it has been proven to be effective in other studies that have used it (Jones, Benes, 
Clark, Denham, Holder, Haynes, Mulgrew, Shepherd, Wilkinson, Singh, Balen, Lashen, & 
Ledger, 2004).  
Procedures 
 A survey was created (see Appendix B) that included demographic information (age, 
ethnicity/race), a confirmation of the participants’ PCOS diagnosis (have you ever been 
diagnosed with PCOS by a licensed professional?) and a question concerning the age at which 
they were first diagnosed (if yes, at what age?), relevant questions related to menopause (when 
was your last period?), and questions to rule out participants who are pregnant or have had a 
hysterectomy. Then, participants were asked to complete the PCOSQ-50. The beginning of the 
survey included an informed consent and possible harm notice. Once all the questions were 
answered, a debriefing appeared at the very end of the survey that informed the participants 
about the intent of the study.  
 To recruit participants, the survey was posted onto the PCOS support group forum 
“PCOS Diva” through Facebook. The survey stated that it is for a study about PCOS. No other 
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information other than that was provided so as to not bias the results. Once the survey was posted 
to the forum, participants were given access to begin taking the survey.  
Participants 
This study required 128 participants (n=128): 64 pre-menopausal women diagnosed with 
PCOS and 64 post-menopausal women diagnosed with PCOS according to a statistical power 
analysis (Faul, Erdfelder, Long, & Buchner, 2007). Criteria for the post-menopausal group 
included women diagnosed with PCOS that have not had a menstruation cycle in 2 years. The 
optimal waiting period between a woman’s last menstruation cycle and the participation in this 
study is two years due to the conclusions drawn by Cohen, Soares, Vitonis, Otto, and Harlow 
(2006) that state the menopause transitional period has a high correlation with depression. 
Therefore, the two year delay criteria is an appropriate amount of time to for participants to pass 
the peri-menopausal state. 
 Exclusion criteria included women who have had a hysterectomy, women who were 
pregnant, and women who have never experienced a menstrual cycle. Participants were at least 
18 years old due to restrictions from the assessment tool (the PCOSQ-50). 
Participants were recruited through PCOS support group advertisements. Women that 
met all the inclusion criteria were selected to participate in the study. The datum from those who 
complete the questionnaire but do not meet the inclusion criteria were discarded. According to a 
study completed in 2013, support groups for PCOS are growing rapidly so this method was 
effective in recruiting the necessary number of participants (Niemi).  
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The two groups consisted of 480 pre-menopausal women with PCOS and 22 post-
menopausal women with PCOS.  In total, 582 women responded to the survey. However, due to 
attrition and unmet inclusion criteria, the total number of participants in the study was 502.  
Demographics for the participants included 15 African American women, 16 Asian/Asian 
American women, 414 Caucasian women, 26 Hispanic/Latina women, 18 Mixed Racial/Biracial 
women, 1 woman that chose not to specify, and 12 women that chose “Other”. A chi-square test 
was completed to test the hypothesis that there would be no difference in the race distribution of 
the 2 groups.  The result was (5 d.f.) = 1.88, p=0.865.  The conclusion is that there is no 
difference in the race distributions. 
In reference to relationship status demographics, 14 of the participants were divorced, 
354 were married, 66 were romantically involved with a partner, 67 were single, and one was 
widowed. A chi-square test was completed to test the hypothesis that there would be no 
difference in the marriage distribution of the 2 groups.  The result was (4 d.f.) = 1.15, p=0.886.  
The conclusion is that there is no difference in the relationship distributions. 
Ages of the participants ranged from 20 to 65. In the pre-menopausal group, the mean 
age was 34.6 and in the post-menopausal group, the mean age was 42.45. There was a significant 
difference in mean age between the two groups (T=5.038, p <0.0001).  
Results 
 The data collected from the surveys was entered into the Statistical Package for the Social 
Sciences (SPSS) program. Each question on the survey had 5 possible answers which were 
Never, Rarely, Sometimes, Often, and Always.  Responses are more negative as regards quality 
of life as they go from Never to Always.  These responses were recoded to the numbers 1, 2, 3, 
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4, and 5, respectively, so that a higher number indicates a more negative quality of life.  For each 
participant the average of those numbers for the 50 questions was calculated to give an overall 
assessment of their quality of life.  Some participants did not answer all questions so the average 
was calculated using scores for those answered. 
The age of the participants at the time of the survey was significantly different between 
the 2 groups (p<0.0001) with the age of the post-menopausal group being almost 8 years older.  
A preliminary regression analysis showed that as age increased the scores decreased (p<0.0001).  
This indicates that an analysis of covariance (ANCOVA) with age as the covariate needed to be 
completed to compare scores in the 2 groups. 
The ANCOVA results showed that the post-menopausal group had a slightly lower mean 
score before adjusting for age (3.18 vs. 3.28) indicating a better quality of life than the pre-
menopausal group.  However, the difference in mean scores was not significantly different 
(p=0.428).  After adjusting for age, the mean scores (3.33 vs. 3.27) of the 2 groups are still not 
significantly different (p=0.610).  The effect of adjusting for age was mainly to increase the 
mean score for the post-menopausal group to be about the same as the pre-menopausal group.   
The conclusion is that there is no significant difference between the mean scores of the 2 groups 
meaning no difference in the quality of life of the 2 groups.  
Discussion 
 This study has both strengths and limitations. A major strength of this study is its 
simplicity; the inclusion criteria are specific, only one assessment is being used, and the results 
should be generalizable to the PCOS community. Another strength is the use of a PCOS based 
assessment instead of a general QOL questionnaire. The use of the PCOSQ-50 is beneficial 
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because it has been normed on the population in question, therefore providing more concise 
results.  
Among the limitations is a diversity component; because the survey was only available 
using a computer or smartphone, individuals of a lower socioeconomic status may not have had 
the opportunity to participate in the study due to a lack of accessibility to the necessary devices. 
Also, diversity proved to be another limitation in terms of race/ethnicity in this study. There was 
a large number of white women (n=414) compared to women of color (n=75). This could be due 
in part to the larger systemic issue involving women of color not having access to the same level 
of healthcare that Caucasian women do (Prather, Fuller, Jeffries, Marshall, Howell, Belyue-
Umole, & King, 2018) and therefore has resulted in less PCOS diagnoses among women of 
color. This is an area of research that needs further evaluation in future studies.  
An additional limitation was the widely varying group sizes (580 pre-menopausal, 22 
post-menopausal). Because the group sizes were so different in size, the results were deemed 
“not clinically significant”. As mentioned in the literature review, there is a large disparity of 
information about women who are post-menopausal that are diagnosed with PCOS. This idea 
leads to the conclusion that women who are post-menopausal are not being diagnosed with the 
same frequency as those who are pre-menopausal. In addition, information about PCOS in 
general is ever-evolving and research is mostly recent. This is indicative of a lack of PCOS 
diagnoses in those participants that were older (and part of the post-menopausal group) due to 
less information being available about PCOS during those women’s pre-menopausal years when 
they were the most symptomatic. It is highly likely that a large majority of women that are post-
menopausal who experience the symptoms associated with PCOS are undiagnosed due to the 
recent relevance of the diagnosis (Wolf, Wattick, Kinkade, & Olfert, 2018). Also, due to issues 
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in healthcare such as ageism, post-menopausal women may not be receiving the same level of 
care compared to women in the pre-menopausal group (Chrisler, Barney, & Palatino, 2016).  
This study contained threats to internal validity that need to be taken into consideration. 
Attrition, or the loss of participants over the course of a study, affected the study. There were 80 
individuals who began the study but did not complete it, making the data for those individuals 
invalid. History was also a threat to internal validity; if a participant was having a worse-than-
normal day when completing the study due to symptom flare-ups or personal life issues, they 
might have responded in a more negative way than they normally would.  
There was also a possible threat of construct validity to this study. Demand 
characteristics, or cues that influence how participants behave, are a potential threat. Because the 
participants were told that they are participating in a study about PCOS, it may have caused them 
to over-report or under-report their symptoms.  
Lastly, there were also threats to external validity. Sample characteristics was an external 
validity threat because the results concluded from this study will only be generalizable to women 
within the PCOS community. Outside of the PCOS community, the results are not applicable. 
There was also a possible threat of reactivity of assessment and reactivity of experimental 
arrangements; the participants were aware that they are a part of a study in general and, more 
specifically, that they are in a study about PCOS. Because of this awareness, participants may 
have changed their answers based on what they believed was being assessed.  
The methods within this study were altered to reduce threats to validity as well as 
limitations by using an assessment that has already been created and normed for the population 
in question. However, the lower validity of the actual QOL assessment (the PCOSQ-50) due to 
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the lack of an acne domain cannot be controlled for until changes to the assessment itself are 
made. It is vital to use the PCOSQ-50 despite its lower validity because it is the only QOL scale 
made for women with PCOS.  
In terms of future research for this topic, more studies need to be completed on women 
with PCOS that are post-menopausal. One way to do so would be to replicate this study with a 
sufficient sample size in both cells in order to achieve statistical power which would eliminate 
the confound of non-significance. However, this has proved to be difficult due to the reasons 
listed above such as post-menopausal women not being diagnosed as frequently as pre-
menopausal women due to scientific disinterest past the child-bearing age.  
It would also be helpful if future research could include more diverse populations. Due to 
the lack of healthcare for women of color as listed above, the results of this study were biased 
towards the results of the white respondents. It may also be helpful to include those women who 
have undergone hysterectomies because, technically, they would then be considered post-
menopausal. However, for the purposes of this study, including women who have experienced 
hysterectomies would have presented more variables than necessary for the simplicity of the 
study design.  
Future research conducted in the areas of child-wish would also contribute to the 
understanding of women in the PCOS community, especially those who are post-menopausal. If 
the quality of life in these women is affected by child-wish or lack-there-of, it could prove to be 
indicative of lower or higher quality of life scores in post-menopausal women. This is a fairly 
new area of research that should be explored in order to better understanding the daily 
functioning and mental health of women with PCOS who are both pre-and-post-menopausal.  
  16 
In addition, research focusing solely on the mental health of post-meonpausal women 
diagnosed with PCOS would also be helpful. In general, there is very little information available 
about what life is like post-menopause for women diagnosed with PCOS. The only solution to 
this problem is to continue to conduct research about this important topic due to its prevalence 
rate in current society. In order for providers to better help and understand their patients, more 
information on post-menopausal women diagnosed with PCOS is a necessity.  
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Appendix A 
Informed Consent 
 I have been asked by Katelyn Baker, a doctoral student from the Illinois School of 
Professional Psychology at Argosy University, Chicago, to participate in her Clinical Research 
Project (CRP) about my experiences of living with Polycystic Ovarian Syndrome (PCOS). I was 
asked to be a possible participant because I have been diagnosed with PCOS. It is estimated that 
124 people will participate in this study. The purpose of this study is to understand the quality of 
life in women who have been diagnosed with PCOS.  
 If I agree to be in this study, I will be asked to complete questionnaires including 
questions about demographic information and symptoms associated with PCOS. This study will 
take approximately 15 minutes to complete.  
 There is minimal risk in this study. However, potential risks that may occur with this 
study are feelings of mild discomfort or distress resulting from being asked to answer questions 
of a more private nature. There are no personal benefits to my participation in this study. Results 
from this study will provide valuable information regarding the effects of PCOS of women of all 
ages and provide possible areas for clinical growth and exploration.  
 All responses are treated as anonymous, and in no case will responses from individual 
participants be identified. Rather, all data will be pooled and published in aggregate form only. I 
understand this study is anonymous, and is done by completing an online survey utilizing Survey 
Money. I am aware, however, that the study is not being run from a “secure” https server of the 
kind typically used to handle credit card transactions, so there is a small possibility that my 
responses could be viewed by unauthorized third parties (e.g., computer hackers). My name will 
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not be identified or associated with my responses to the questionnaires. The data will be sent to 
the researcher anonymously when completed and given a code. My IP address will not be 
recorded as the IP address tracking will be disabled in order to preserve participant anonymity. 
The records of this study will be kept private. No words linking me to the study will be included 
in any sort of report that might be published. The data will be stored securely at the researcher’s 
home and only Katelyn Baker and her supervisor, Dr. Christopher Rector, will have access to the 
records. After three years, all collected data will be destroyed. I have a right to get a summary of 
the results of this research if I would like to have them.  
 I understand that I will not be compensated for this study. I understand that my 
participation is strictly voluntary. My decision regarding my participation will not affect my 
current or future relations with the Illinois School of Professional Psychology at Argosy 
University, Chicago. If I decide to participate, I am free to refuse to answer any of the questions 
that may make me uncomfortable. I can withdraw at any time without any penalty.  
 I understand that this research study will be reviewed and certified by the Institutional 
Review Board, Argosy University, Chicago. For research-related questions or issues regarding 
participants’ rights, I can contact the Institutional Review Board through the IRB chair, Leah 
Horvath, Ph.D at (312) 777-7681, lhorvath@argosy.edu, Illinois School of Professional 
Psychology at Argosy University, Chicago, 225 N. Michigan Ave., Suite 1300, Chicago, IL 
60601.  
I have read and understand the explanation provided to me. I have had all my questions 
answered to my satisfaction, and I voluntarily agree to participate in this study. By 
completing the online survey, I consent to participate in the study.   
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If you are 18 years of age or older, understand the statements above, and freely consent to 
participate in the study, click on the “I agree” button to begin the experiment.  
Participants are encouraged to print a copy of this informed consent for their records.  
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Appendix B 
Demographic Information Survey 




If you answered yes to the above question, at what age were you diagnosed? 
● (Blank space for fill in answer) 
Racial/Ethnic Identity 
● Caucasian/White/European 
● African American/Black 
● Asian/Asian American 
● Mixed Racial/Biracial 
● Latino/Latina/Hispanic 
● Jewish 




● I Prefer not to answer 
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 Age 






● Romantically involved with a partner 
When did your last menstrual cycle occur?  
● (blank space for a fill in answer) 
Are you currently pregnant? 
● Yes 
● No 




  26 
Appendix C 
PCOSQ-50 
Polycystic Ovary Syndrome Questionnaire (PCOSQ-50)—Self-Administered Instructions: 
The questions concern your health-related issues. Please respond to each question by checking  
the box with the rating that best reflects how you feel. Choose only one option for each question. 
There is no right or wrong answer. Just choose the option that is closest to how you feel. Options 
for every question are as follows: never, rarely, sometimes, often, and always.  
Section A: Psychosocial and emotional 
In the past 4 weeks how often have you 
1. Suffered from bad mood due to PCOS? 
2. Experienced impatience due to PCOS? 
3.  Blamed yourself for having PCOS?         
4. Experienced trouble dealing with others? 
5. Suffered from low self-esteem due to PCOS? 
6. Experienced aggressiveness due to PCOS? 
7. Felt pessimistic about the treatment? 
8. Suffered from embarrassment due to your appearance? 
9.  Felt different to normal women?         
10. Experienced lack of control of emotions? 
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11.  Felt ugly or unattractive?         
12.  Felt easily tired?       
Section B: Fertility 
In the past 4 weeks how often have you 
1.  Felt sad seeing children?         
2.  Felt sad seeing pregnant women?         
3.Experienced concern about infertility? 
4. Felt you will accept all other PCOS manifestations if assured of pregnancy? 
5.  Felt fear of abortion?         
6. Felt concerned about infertility in the future? 
7. Experienced fear of divorce or separation? 
8. Felt uselessness of sexual intercourse due to infertility? 
9. Experienced concern about the long term effects of PCOS medication? 
Section C: Sexual function 
*fill for those with partner 
In the past 4 weeks how often have you 
1.  Felt unsatisfied with sex?         
2. Experienced lack of sexual stimulation? 
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3.  Experienced lack of sexual desire?         
4. Experienced lack of lubrication during sexual intercourse? 
5.  Experienced lack of orgasm?         
6. Felt ashamed of sexual coldness/unresponsiveness? 
7. Experienced loss of libido because of PCOS? 
Section D: Obesity and menstrual disorders 
In the past 4 weeks how often have you 
1. Felt concerned about being overweight? 
2. Felt the need to decrease your weight to control PCOS status? 
3. Felt concerned about a fast return to your previous weight after any weight loss? 
4. Felt concerned about the complete cessation of menstruation? 
5. Felt concerned about menstruation at long intervals? 
6. Felt willingness to reduce your weight to be more attractive for your partner? 
7. Experienced fear of diseases such as diabetes, hypertension and heart disease? 
8. Felt the urge to abandon treatments because of repetitive visits to doctors? 
9. Experienced fear of cancer?       
Section E: Hirsutism disorders 
In the past 4 weeks how often have you 
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1. Felt embarrassed because of excess facial hair? 
2. Felt concerned about the progression of excess body and facial hair? 
3. Felt concerned about having excess facial hair? 
4. Felt concerned about rapid regrowth of unwanted hair after its removal? 
5. Felt embarrassed because of having excess body hair? 
6. Experienced the need to cover your body and face because of excess hair? 
Section G: Coping 
In the past 4 weeks how often have you 
1. Felt a lack of family support and acceptance of your disease? 
2. Felt lack of satisfaction with being a woman? 
3.  Felt the desperate need for a cure?         
4. Felt complain with others about PCOS? 
5. Felt difficult communicating with others with PCOS? 
6. Felt lack of satisfaction with your appearance (self image)? 
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Appendix D 
Debriefing Statement and Referrals 
Thank you for your participation in this research on the quality of life in women 
diagnosed with Poly Cystic Ovarian Syndrome.  Multiple-choice/scale questionnaires were used 
for participants in this study.  The goal of the questionnaires was to gather information on the 
quality of life in women diagnosed with PCOS both before and after menopause. It was 
hypothesized that women diagnosed with PCOS that are post-menopausal will have an overall 
higher quality of life.  
If you feel that you need assistance with issues that are caused by feelings or experiences 
as a result of this study, please utilize the list of referrals that has been provided below.  
Current research has very little information about what PCOS looks like from a post-
menopausal light.  Your participation was important in helping researchers understand the 
differences in symptomology and overall quality of life of women with PCOS who are both pre- 
and post-menopausal. 
Final results will be available from the investigator, Katelyn Baker.  You may contact me 
at (219) 765-8584 to receive a copy of the final report.  All results will be grouped together; 
therefore individual results are not available.  Your participation, including your name and 
answers, will remain absolutely confidential, even if the report is published. 
If you have any additional questions regarding this research, please contact me using the 
information provided above. 
  31 
Referrals 
National Suicide Prevention Lifeline: 1 (800) 273-8255 
National Alliance on Mental Illness: 1 (800) 950-6264 
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Appendix E 
Permissions 
4/18/2018 Mail - Kebaker94@stu.argosy.edu 
Re: Request for research participation 
Hi Katelyn,  
Sure would be happy to share if it gets approved. 
Kindly, 
Amy Medling 
Health Coach, PCOS Diva 
amy@pcosdiva.com 
www.pcosdiva.com 
New Book! Preorder my book Healing PCOS, on sale May 1st! Click to preorder and claim 
your bonus items. 
The views and recommendations shared by PCOS Diva LLC and pcosdiva.com, as well as the 
information contained in this email, if any, are for 
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general health information only and do not constitute, and are not intended to be a substitute for 
professional medical advice regarding an individual’ s specific health condition. The information 
is intended to provide accurate and helpful health information. The information is not intended as 
medical advice for individual problems or for making a diagnosis of a medical condition or an 
evaluation as to the risks and benefits of taking a particular drug or product. 
On Mar 20, 2018, at 1:57 PM, Katelyn Baker <Kebaker94@stu.argosy .edu> wrote: 
Hello! 
My name is Katelyn Baker and I am a third year clinical psychology doctoral student at the 
Illinois School of Professional Psychology at Argosy University, Chicago. I am in the midst of 
working on my Clinical Research Project (more commonly known as a dissertation) and my 
topic is on PCOS. I'm writing in the hopes that, once my study gets approved, you would be 
willing to share a brief survey on the PCOS Diva Facebook page so that women with PCOS may 
be able to participate in my study?  
Please let me know your thoughts as well as any questions you might have. My contact 
information is listed below.  
Thank you, 
Katelyn Baker 
Therapy Extern at TherapyWorks, Valparaiso/Michigan City 
Third Year Clinical Psychology Doctorate Student 
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